EPHA2 and neoplasm: It is frequently overexpressed in malignant cells and has been suggested to be an important factor in tumour growth, survival, metastatic processes, and angiogenesis [69,105] Our findings add to the body of evidence [70,90] suggesting the influence of EphA2 on tumour response to dasatinib.